Recent News

• 05.28.2025 - Craig-Hallum 22nd Annual Institutional Investor Conference
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference
• 05.14.2025 - First Quarter 2025 Financial Results and Conference Call
• 05.14.2025 - scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.14.2025 - scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.07.2025 - scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
• 05.07.2025 - scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
• 05.07.2025 - The Citizens Life Sciences Conference
• 05.07.2025 - The Citizens Life Sciences Conference
• 05.01.2025 - scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Recent Filings

• 04.28.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.21.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.21.2025 - DEF 14A Other definitive proxy statements
• 03.19.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.19.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.19.2025 - EX-99.1 EX-99.1